Pharmacognosy 2021

4 papers
In 2021, research in Pharmacognosy emphasized the pharmacological evaluation and chemical profiling of plant-derived compounds. A primary focus was the investigation of natural products in treating specific pathological conditions using animal models. Key studies examined the inhibitory effects of ginsenosides on skin pigmentation in melasma and the neuroprotective potential of costunolide in mitigating apoptosis following oxygen-glucose deprivation. Methodological trends included the use of gas chromatography-mass spectrometry (GC-MS) for the phytocomponent analysis of species such as Premna latifolia Roxb. Additionally, research explored the immunomodulatory effects of brucine in allergic rhinitis, specifically targeting T-helper cytokine signaling and pathways like NF-κB and STAT3. Prolific contributors to this year's research included authors such as Chunlin Zhao, Shengxue Zhou, and Brijesh Kumar. These works collectively highlight a focus on identifying the molecular mechanisms through which botanical extracts influence dermatological, neurological, and respiratory health.

Papers

Title
Costunolide attenuates oxygen-glucose deprivation/reoxygenation-induced apoptosis in mouse brain slice through inhibiting caspase expression
GC-MS analysis of Phytocomponents in the Methanol Extract of Premna latifolia Roxb
Salutary effect of brucine in ovalbumin-induced allergic rhinitis: Role of t-helper 1, t-helper 2 cytokines, nuclear factor-kappa b, stat3, and rorc signaling in mouse models
The inhibitory effects of different kinds of ginsenosides on skin pigmentation in melasma mice model